--- a
+++ b/clusters/9knumclustersv2/clust_1034.txt
@@ -0,0 +1,86 @@
+Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . times ULN
+Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) < . times the institutional ULN (unless elevated secondary to lymphomatous involvement of the liver, in which case the AST/ALT must be =<  times the institutional ULN)
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) no greater than . times the ULN
+Participants must have total bilirubin less than or equal to . times the upper limit of normal (ULN), and aspartate aminotransferase and alanine aminotransferase less than or equal to . times ULN.
+Adequate liver function (total bilirubin ? . times the ULN, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ? . times ULN
+Within  days prior to enrollment: Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) no greater than . times the ULN
+Aspartate aminotransferase (AST) <  times ULN
+Alanine aminotransferase (ALT) <  times ULN
+Serum alkaline phosphatase, alanine aminotransferase, and aspartate aminotransferase ? times the upper limit of normal (ULN); ?  times ULN if there is liver or bone involvement.
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) < . times ULN
+Adequate hepatic function, with bilirubin <  times the upper limit of normal (ULN), and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) <  times ULN
+Aspartate aminotransferase (AST) >  times the upper limit of normal (ULN) or alanine aminotransferase (ALT) >  times ULN
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ?.  institutional ULN (patients with hepatic metastases must have AST/ALT ? times ULN).
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ?  times the ULN; if liver metastases are present, then ?  times the ULN is allowed.
+Alanine aminotransferase (ALT) greater than . times the ULN in the absence of known hepatic metastases
+Aspartate aminotransferase (AST) greater than . times the ULN in the absence of known hepatic metastases
+AST (aspartate aminotransferase) and ALT (alanine aminotransferase) =<  times ULN (measured within  days of registration)
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) if no hepatic metastasis =< . times x ULN
+Alanine aminotransferase (ALT) and Aspartate aminotransferase (AST) ?. times the upper limit of normal (ULN), or ? times the ULN for patients with liver metastases;
+Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) > . times ULN at the time of screening
+Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . times ULN
+Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >  times the ULN
+Have serum aspartate aminotransferase (AST) > times upper limit of normal (ULN) at screening, or serum alanine aminotransferase (ALT) > times ULN at screening, or total bilirubin >=. x ULN at screening (except for documented Gilbert's syndrome), as analyzed by local or central lab.
+Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) =<  times ULN or =<  times ULN if patient has documented liver metastases
+Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) <  times ULN or <  times ULN if patient has documented liver metastases
+Alanine aminotransferase (ALT), and aspartate aminotransferase (AST) =< . times ULN
+Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . times the ULN
+Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . times ULN (=< . x ULN if due to leukemic involvement)
+PRIOR TO CELL PROCUREMENT: Aspartate aminotransferase (AST) ?  times ULN
+Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >  times ULN
+Alanine aminotransferase (ALT) =<  times the ULN
+Aspartate aminotransferase (AST) =<  times the ULN
+alkaline phosphatase, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) less than or equal to  times ULN.
+EXCLUSION CRITERIA FOR ENROLLMENT: AST (aspartate aminotransferase)/ALT (alanine aminotransferase) >  times the ULN
+Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) <  times above the ULN, ALT and AST can be <  times ULN if patients have hepatic involvement
+Within  days prior to CD: Aspartate aminotransferase (AST) < . times ULN and alanine aminotransferase (ALT) < . times ULN
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =<  times ULN
+Hepatic enzymes (aspartate aminotransferase [AST], alanine aminotransferase [ALT]) =< . times the institutional ULN
+Alanine aminotransferase (ALT) =<  times the ULN or aspartate aminotransferase (AST) =<  times the ULN; these values must be obtained within four weeks before protocol entry
+Aspartate aminotransferase (AST) <  times the ULN
+Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) < . times ULN
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels >= . times the ULN or >=  times the ULN if liver metastases are present
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . times ULN (unless elevated due to secondary lymphomatous involvement of the liver)
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . times ULN
+Serum/plasma alanine aminotransferase (ALT), and aspartate aminotransferase (AST) ? times the upper limit of normal (ULN); ? times ULN if there is liver or bone involvement.
+Serum/plasma alkaline phosphatase, alanine aminotransferase (ALT), and aspartate aminotransferase (AST) ? times the upper limit of normal (ULN); ?  times ULN if there is liver or bone involvement.
+Serum alanine aminotransferase <  times the upper limit of normal (ULN); Note: If elevated liver enzymes are related to disease alanine aminotransferase (ALT) should be <  times ULN
+Adequate hepatic function defined as: total bilirubin ?. times the institutional ULN; alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ?. times the institutional ULN
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . times ULN
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) <  times the ULN
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . times ULN
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) less than or equal to . times the ULN, unless subjects have liver metastasis, in which case both AST and ALT must be less than or equal to  times the ULN
+AST (aspartate aminotransferase) and ALT (alanine aminotransferase) =<  times ULN
+Alanine aminotransferase (ALT) < . times ULN
+Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) =< . times ULN
+Total bilirubin level ?. times institutional upper limit of normal (ULN), alanine aminotransferase or aspartate aminotransferase ? x ULN
+Serum alanine aminotransferase or aspartate aminotransferase >  times ULN
+Alanine aminotransferase (ALT) =< . times ULN*
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) < . times ULN
+Patient has poor liver function (> . times normal of alanine aminotransferase [ALT]/aspartate aminotransferase [AST]) suggestive of cirrhosis or steatohepatitis
+Serum alanine aminotransferase or aspartate aminotransferase <  times the ULN Note: If elevated liver enzymes, above the ULN, are related to disease; contact medical monitor to discuss.
+Hepatic enzymes (aspartate aminotransferase [AST], alanine aminotransferase [ALT]) =< . times the institutional ULN
+Alanine aminotransferase (ALT) =< . times ULN
+Hepatic enzymes (aspartate aminotransferase [AST], alanine aminotransferase [ALT]) =< . times the institutional ULN
+Alanine aminotransferase (ALT) =< . times ULN
+Alanine aminotransferase and aspartate aminotransferase </=  times the ULN
+Patients must have adequate hepatic function with alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . times ULN within one week prior to treatment
+alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ?  times the ULN for the reference lab
+Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . times ULN
+Subject has total serum bilirubin ?. times the upper limit of normal (ULN),serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) >  times ULN, or albumin ? . g/dL at Screening.
+Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) </=. times ULN (</= times ULN for subjects with liver involvement of their cancer)
+Serum alanine aminotransferase or aspartate aminotransferase <  times the ULN. Note: If elevated liver enzymes are related to disease; contact medical monitor to discuss.
+Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >  times the ULN.
+Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels less than . times ULN at study entry
+Adequate hepatic function, with bilirubin <  times the upper limit of normal (ULN), and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) < . times ULN
+Adequate hepatic function within  days prior to randomization, with bilirubin < . times the upper limit of normal (ULN), and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) <  times the ULN.
+Serum alanine aminotransferase < . times the ULN.
+Aspartate aminotransferase (AST) or alanine transaminase (ALT) >  times ULN
+Serum alanine aminotransferase or aspartate aminotransferase <  times the ULN. Note:If elevated liver enzymes are related to disease; contact medical monitor to discuss.
+Aspartate aminotransferase (AST) =<  times ULN
+Aspartate aminotransferase (AST) =<  times ULN
+Obtained within  days prior to initiation of treatment: Serum aspartate aminotransferase (AST), alanine aminotransferase (ALT) < . times ULN
+Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . times ULN
+Liver function: total bilirubin ? . times the upper limit of normal (ULN) of each institution, aspartate aminotransferase and alanine aminotransferase ?  times the ULN range of each institution.
+Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ? . times ULN (?  times ULN for patients with impaired liver function due primary tumor or metastatic disease)
+Serum/plasma alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ? times the upper limit of normal (ULN); ? times ULN if there is liver or bone involvement.